COMMUNIQUÉS West-GlobeNewswire

-
Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease
18/04/2018 -
CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange
18/04/2018 -
Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders
18/04/2018 -
Pre-Clinical Data Demonstrating Promising Potential of Prexigebersen as Treatment for Solid Tumors in Gynecologic Malignancies Presented at American Association for Cancer Research Annual Meeting
18/04/2018 -
Krystal Biotech Presents Their Skin TARgeted Delivery Platform at the World Orphan Drug Congress USA
18/04/2018 -
Sientra Receives FDA Approval of PMA Supplement
18/04/2018 -
Paratek Pharmaceuticals, Inc. Announces Proposed Private Offering of $125 Million of Convertible Senior Subordinated Notes due 2024
18/04/2018 -
CAPS® Experts & Quality Assurance Programs to be Featured at NHIA 2018
18/04/2018 -
Terveystalo Plc recognizes deferred tax assets with a positive, one-time net result impact of approximately EUR 13 million in the first quarter of 2018
18/04/2018 -
NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting
18/04/2018 -
Cambridge Innovation Institute Announces the Acquisition of the AI World Conference & Expo and AI Trends
18/04/2018 -
21st Century Oncology Appoints Chief Executive Officer – Kimberly Commins-Tzoumakas
18/04/2018 -
Addiction Experts from Detox of South Florida Publish their list of Best Rehab Centers for 2018
18/04/2018 -
HEALTH FOUNDATION ELECTS DOROTHY TERRELL TO BOARD OF DIRECTORS
18/04/2018 -
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting of Shareholders
18/04/2018 -
Private Placement Closes
18/04/2018 -
Eloxx Pharmaceuticals Announces that Two Abstracts for ELX-02 Have Been Accepted for Presentation at the 41st European Cystic Fibrosis Conference
18/04/2018 -
Shire plc : Notice of Results
18/04/2018 -
Active Biotech: Notice of Annual General Meeting of Shareholders
18/04/2018
Pages